CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
3.980
-0.172 (-4.14%)
At close: Jun 26, 2026, 4:00 PM EDT
4.050
+0.070 (1.76%)
After-hours: Jun 26, 2026, 7:39 PM EDT
CNS Pharmaceuticals Employees
CNS Pharmaceuticals had 8 employees as of December 31, 2025. The number of employees increased by 3 or 60.00% compared to the previous year.
Employees
8
Change (1Y)
3
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$2,060,786
Market Cap
5.82M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| NextCure | 40 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| Soligenix | 14 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| Acurx Pharmaceuticals | 4 |
CNSP News
- 18 days ago - CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment - Accesswire
- 5 weeks ago - CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress - Accesswire
- 5 weeks ago - CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders - TheFly
- 5 weeks ago - CNS Pharmaceuticals Registration statement: Registration filing - Filings
- 6 weeks ago - CNS Pharmaceuticals reports Q1 EPS ($7.30) vs. ($18.93) last year - TheFly
- 6 weeks ago - CNS Pharmaceuticals sees cash runway ‘beyond’ twelve months - TheFly
- 6 weeks ago - CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress - Accesswire
- 6 weeks ago - CNS Pharmaceuticals Quarterly report: Q1 2026 - Filings